1. Home
  2. ATLN vs JCE Comparison

ATLN vs JCE Comparison

Compare ATLN & JCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLN
  • JCE
  • Stock Information
  • Founded
  • ATLN 2014
  • JCE 2007
  • Country
  • ATLN United States
  • JCE United States
  • Employees
  • ATLN N/A
  • JCE N/A
  • Industry
  • ATLN
  • JCE Trusts Except Educational Religious and Charitable
  • Sector
  • ATLN
  • JCE Finance
  • Exchange
  • ATLN NYSE
  • JCE Nasdaq
  • Market Cap
  • ATLN 269.5M
  • JCE 252.4M
  • IPO Year
  • ATLN 2021
  • JCE N/A
  • Fundamental
  • Price
  • ATLN $3.53
  • JCE $15.92
  • Analyst Decision
  • ATLN
  • JCE
  • Analyst Count
  • ATLN 0
  • JCE 0
  • Target Price
  • ATLN N/A
  • JCE N/A
  • AVG Volume (30 Days)
  • ATLN 32.2K
  • JCE 49.7K
  • Earning Date
  • ATLN 01-01-0001
  • JCE 01-01-0001
  • Dividend Yield
  • ATLN N/A
  • JCE 9.26%
  • EPS Growth
  • ATLN N/A
  • JCE N/A
  • EPS
  • ATLN N/A
  • JCE N/A
  • Revenue
  • ATLN $429,260,149.00
  • JCE N/A
  • Revenue This Year
  • ATLN N/A
  • JCE N/A
  • Revenue Next Year
  • ATLN N/A
  • JCE N/A
  • P/E Ratio
  • ATLN N/A
  • JCE N/A
  • Revenue Growth
  • ATLN 5.50
  • JCE N/A
  • 52 Week Low
  • ATLN $1.30
  • JCE $11.64
  • 52 Week High
  • ATLN $8.98
  • JCE $14.28
  • Technical
  • Relative Strength Index (RSI)
  • ATLN N/A
  • JCE 49.86
  • Support Level
  • ATLN N/A
  • JCE $15.62
  • Resistance Level
  • ATLN N/A
  • JCE $16.00
  • Average True Range (ATR)
  • ATLN 0.00
  • JCE 0.23
  • MACD
  • ATLN 0.00
  • JCE 0.00
  • Stochastic Oscillator
  • ATLN 0.00
  • JCE 42.11

About ATLN ATLANTIC INTERNATIONAL CORP

Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.

About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest

Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities (the Options Strategy).

Share on Social Networks: